Vasovist® for imaging ischemic and congenital heart disease

Sebastian Kelle, Gerald F. Greil, Reza Razavi, Eike Nagel

Research output: Chapter in Book/Report/Conference proceedingChapter

1 Scopus citations

Abstract

Cardiovascular MR (CMR) offers various options to detect ischemia in patients with known or suspected coronary artery disease (CAD). Over the past few years, the evidence on many indications in the diagnosis of CAD and heart failure with CMR has accumulated [1, 2]. CMR provides combined diagnostic information, such as visualization of the vascular tree, cardiac anatomy and function, as well as measurements of blood flow in the vessels, ventricular wall motion, myocardial perfusion and viability. Most of the current applications for CMR imaging use contrast agents, either to improve image quality (e.g. angiography) or to generate contrast (e.g. delayed gadolinium enhancement or perfusion).

Original languageEnglish (US)
Title of host publicationClinical Blood Pool MR Imaging
PublisherSpringer Berlin Heidelberg
Pages159-168
Number of pages10
ISBN (Print)9783540778608
DOIs
StatePublished - Dec 1 2008

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Vasovist® for imaging ischemic and congenital heart disease'. Together they form a unique fingerprint.

  • Cite this

    Kelle, S., Greil, G. F., Razavi, R., & Nagel, E. (2008). Vasovist® for imaging ischemic and congenital heart disease. In Clinical Blood Pool MR Imaging (pp. 159-168). Springer Berlin Heidelberg. https://doi.org/10.1007/978-3-540-77861-5_14